Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
75,279,174
-
Share change
-
-1,268,809
-
Total reported value
-
$283,248,825
-
Put/Call ratio
-
100%
-
Price per share
-
$3.76
-
Number of holders
-
130
-
Value change
-
-$5,512,639
-
Number of buys
-
55
-
Number of sells
-
46
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q2 2018
As of 30 Jun 2018,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,279,174 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, ABRAMS CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, RICE HALL JAMES & ASSOCIATES, LLC, NORGES BANK, PKO Investment Management Joint-Stock Co, CLEARBRIDGE, LLC, and NORTHERN TRUST CORP.
This page lists
130
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.